Utah Medical Products (UTMD) EBIAT (2010 - 2026)

Utah Medical Products' EBIAT history runs 17 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, EBIAT fell 14.37% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $10.8 million (down 16.29% YoY), while the FY2025 annual figure was $11.3 million, down 18.65% from the prior year.
• EBIAT was $2.6 million for Q1 2026 at Utah Medical Products, up from $2.6 million in the prior quarter.
• In the past five years, EBIAT ranged from a high of $4.6 million in Q4 2022 to a low of $2.6 million in Q4 2025.
• Historically, EBIAT has averaged $3.6 million across 5 years, with a median of $3.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: EBIAT climbed 19.76% in 2022, then sank 32.31% in 2024.
• A 5-year view of EBIAT shows it stood at $4.6 million in 2022, then fell by 5.88% to $4.3 million in 2023, then tumbled by 32.31% to $2.9 million in 2024, then slipped by 11.61% to $2.6 million in 2025, then advanced by 1.52% to $2.6 million in 2026.
• The last three EBIAT figures came in at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.